1. Home
  2. FINV vs AMPH Comparison

FINV vs AMPH Comparison

Compare FINV & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FINV

FinVolution Group

HOLD

Current Price

$4.83

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$20.98

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FINV
AMPH
Founded
2007
1996
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
971.8M
IPO Year
2017
2005

Fundamental Metrics

Financial Performance
Metric
FINV
AMPH
Price
$4.83
$20.98
Analyst Decision
Strong Buy
Buy
Analyst Count
1
8
Target Price
$12.10
$28.38
AVG Volume (30 Days)
862.8K
615.3K
Earning Date
05-19-2026
05-07-2026
Dividend Yield
6.09%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$719,887,000.00
Revenue This Year
N/A
$6.90
Revenue Next Year
$10.58
$4.64
P/E Ratio
$3.87
$150.14
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$16.65
52 Week High
$10.90
$31.26

Technical Indicators

Market Signals
Indicator
FINV
AMPH
Relative Strength Index (RSI) 46.21 58.80
Support Level $4.67 $18.92
Resistance Level $5.23 $24.61
Average True Range (ATR) 0.16 0.83
MACD -0.02 0.11
Stochastic Oscillator 39.11 98.15

Price Performance

Historical Comparison
FINV
AMPH

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: